Leap Therapeutics (LPTX) Misses Q1 EPS by 37c

Leap Therapeutics (NASDAQ: LPTX) reported Q1 EPS of ($0.37).

For earnings history and earnings-related data on Leap Therapeutics (LPTX) click here.

You May Also Be Interested In

• Evercore ISI Starts Credo Tech (CRDO) at Outperform
• Fervo Energy, Nvidia, and PNNL to build geothermal digital twin
• Cadence Design Systems (CDNS) call put ratio 1 call to 2.9 puts